Dr. Harley has received a R01 grant from NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) entitled ‘Gradient biomaterials to investigate niche regulation of hematopoiesis.’ This grant will support our work to develop an engineered bone marrow biomaterial. We will be using this platform to optimizing artificial bone marrow systems to study the onset and growth of hematologic disease as well as processes associated with hematopoietic stem cell transplant failure.
Engineering cellular microenvironments and microstructures